{
    "nctId": "NCT02883699",
    "briefTitle": "Individually Tailored Training Prescriptions in Cancer Patients: The TOP Study",
    "officialTitle": "Individually Tailored Training Prescriptions in Cancer Patients: The TOP Study",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 132,
    "primaryOutcomeMeasure": "Change in maximal oxygen uptake (VO2peak) (endurance training groups only)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosed with early stage breast cancer (M0) or prostate cancer (M0 or M1 with PSA evidence of stable disease)\n* 6 to 52 weeks after the end of primary therapy\n* \u226518 to 75 years of age\n* no regular endurance or resistance training (\u2265 one session per week) since diagnosis or within the last 6 months\n* sufficient German language skills\n* willing/ able to train at the provided exercise facilities twice per week and to take part in the scheduled testing\n* signed informed consent.\n\nExclusion Criteria:\n\n* diagnosed with additional other cancer\n* brain or bone metastases in M1 prostate cancer patients\n* heart failure \\>NYHA III, unstable angina pectoris or severe arrhythmia\n* uncontrolled hypertension\n* reduced standing or walking ability\n* any other comorbidities that preclude participation in exercise testing or training.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}